Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase II study

Trial Profile

Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase II study

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Cisplatin; Gemcitabine
  • Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
  • Focus Therapeutic Use
  • Acronyms ABC-01
  • Most Recent Events

    • 31 May 2012 Actual initiation date (11 Jan 2002) added as reported by ISRCTN: Current Controlled Trials.
    • 31 May 2012 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
    • 31 May 2012 New source identified and integrated (ISRCTN: Current Controlled Trials record, 96194255).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top